Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Line S. Bisgaard, Christina Christoffersen

Purpose of review
In 2011, the crystal structure of apolipoprotein M (apoM) and its capacity to bind sphingosine-1-phosphate (S1P) was characterized. Since then, a variety of studies has increased our knowledge on apoM biology and functionality. From being an unknown and hardly significant player in overall metabolism, apoM has gained significant interest.

Recent findings
Key discoveries in the last 2 years have indicated that the apoM/S1P complex has important roles in lipid metabolism (affecting triglyceride turnover), inflammation (a marker of severe sepsis and potentially providing anti-inflammatory signaling) and kidney biology (potential to protect against immunoglobulin A nephropathy).

Summary
Several studies suggest a potential for apoM/S1P as biomarkers for inflammation, sepsis and nephropathy. Also, a novel chaperone is characterized and could have potential as a drug for treatment in inflammation and nephropathy.
OriginalsprogEngelsk
TidsskriftCurrent Opinion in Lipidology
Vol/bind30
Udgave nummer3
Sider (fra-til)212-217
ISSN0957-9672
DOI
StatusUdgivet - 2019

ID: 227785225